USPTO serial 79252947
LUMEVOQ
Reviewed by CopyMark Law Group
Reg. 5974489Status 709
- Filing date
- Status date
- Registration date
- Feb 4, 2020
- Examiner
- MACFARLANE, JAMES W
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LUMEVOQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John T.D. Bathke
John T.D. Bathke IpHorgan Ltd.195 Arlington Heights Rd., Ste. 125Buffalo Grove, IL 60089UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for the treatment of ocular diseases; Medicines for human purposes for the treatment of ocular diseases | SECTION 71 - CANCELLED | — |
| 016 | Pamphlets and information bulletins in the field of ocular diseases; presentation folders; printed booklets in the field of ocular diseases; partially printed forms; printed teaching activity guides in the field of ocular diseases; educational books in the field of ocular diseases; information booklets in the field of ocular diseases; training manuals and instruction manuals for teaching purposes in the field of ocular diseases; instruction manuals in the field of ocular diseases; printed educational and training materials in the field of ocular diseases; instruction and teaching material, excluding apparatus, in the field of ocular diseases; educational publications, namely, books, booklets and instruction manuals in the field of ocular diseases; printed questionnaires on ocular diseases; specialist journals in the field of ocular diseases; printed teaching and instructional materials in the field of ocular diseases, all these products intended for patients and physicians in the medical field and in particular the field of eye diseases | SECTION 71 - CANCELLED | — |
| 035 | Administrative business support staff services for patients with a view to submitting requests in the medical field in particular for the management of eye diseases | SECTION 71 - CANCELLED | — |
| 041 | Education services in the nature of classes and seminars in the medical field and in particular that of eye diseases | SECTION 71 - CANCELLED | — |
| 042 | Scientific research in the field of eye diseases | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GENSIGHT BIOLOGICS
- Other trademarks owned by GENSIGHT BIOLOGICS
- Other trademarks owned by GENSIGHT BIOLOGICS
- Other trademarks in Class 005
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named LUMEVOQ
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 21, 2026 | C71T | CANCELLED SECTION 71 | — |
| Feb 4, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 5, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 18, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 18, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 4, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 4, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 19, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 19, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 15, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 30, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 30, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 30, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 15, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 18, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 18, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 17, 2019 | ALIE | ASSIGNED TO LIE | — |
| Sep 11, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 12, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 23, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 23, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 17, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 16, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 8, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 4, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 28, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |